RxDoctor Payments Data
★ My doctorsLook up a doctor →

Michael Lee

Family Medicine · Durant, OKNPI 1124020193

Payments from drug & device makers

$1,356in general payments, 2019–2025

Across 92 payments — averaging $14.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$206
  • Lilly USA, LLC$153
  • Novo Nordisk$150
  • Johnson & Johnson$149
  • Astellas Pharma US Inc$96
  • Amgen$89
  • plus $514 from 15 others

What the payments were for

  • Food & beverage$1,29195%
  • Education$655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)18$206
Lilly USA, LLC10$153
Novo Nordisk10$150
Johnson & Johnson8$149
Astellas Pharma US Inc3$96
Amgen6$89
Eisai Inc.4$60
Takeda Pharmaceuticals U.S.A., Inc.5$60
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$55
AstraZeneca4$55
Currax Pharmaceuticals LLC3$38
GSK3$38
Sanofi-aventis U.S. LLC2$38
Merck3$36
Pfizer2$34
Mylan Specialty L.p.2$30
Ironwood Pharmaceuticals, Inc1$18
Biohaven Pharmaceuticals, Inc.1$16
Medtronic1$12
Teva Pharmaceuticals USA, Inc.1$12
Nalpropion Pharmaceuticals LLC1$11

How this compares

$1,356 in reported general payments places this provider in the 65th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma →

Other family medicine in Durant

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →